Upstream Processing

Cobra Biologics moves to beef up mAb capacity

Cobra Biologics moves to beef up mAb capacity

By Gareth Macdonald

Corba Biologics has opted for a HyClone bioreactor to boost its antibody production capacity citing customer demand and biosimilars as the drivers for the investment.

Horizon Licenses ZFN Tech from Sigma-Aldrich

Horizon Licenses ZFN Tech from Sigma-Aldrich

By Dan Stanton

Horizon Discovery has licensed a zinc finger nuclease (ZFN) technology from Sigma-Aldrich and says the combination with its own platform will be “a big step forward in gene editing.”

Single-Use Growth Offsets Pall's Muted Results

Single-Use Growth Offsets Pall's Muted Results

By Dan Stanton

Pall Corporation says it will continue to invest in single-use systems after reporting substantially higher growth in sales compared to stainless steel systems for the 2013 FY.

Pfizer Preps for Pipeline with $130m Irish Investment

Correction

Pfizer Preps for Pipeline with $130m Irish Investment

By Dan Stanton

After patent expiration led to facility shuttering and cutbacks, Irish manufacturing will receive a $130m (€100m) boost to prepare for Pfizer’s new pipeline, the company says.

Thermo Fisher Acquires Life Tech for $13.6B

Update

Thermo Fisher Acquires Life Tech for $13.6B

By Zachary Brennan

Thermo Fisher Scientific has agreed to purchase genetic testing equipment maker Life Technologies for $13.6B in one of the biggest acquisitions of the year.

Biosimilars: Is the Market Getting Too Much Attention?

Biosimilars: Is the Market Getting Too Much Attention?

By Zachary Brennan

As anticipation swells over how the biosimilar market will shape up in the US, some contract biologic manufacturing executives don’t seem to think the size of the market is worth all of the hype yet.

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

By Natalie Morrison

Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.

Follow us

Webinars